Sign in

NCT05709002Completed

Smoking, Stress, HIV and Mobile Technology

A Fully Automated and Culturally-Adapted mHealth Intervention for Smoking Cessation Among Black Smokers With HIV

Source: ClinicalTrials.gov · Last updated 2 Jul 2026

Brief summary (registry, in English)

The present investigation aims to address disparities in cigarette use outcomes among Black/African American adults with HIV. The specific aims of this study are: (1) To modify a recently developed, culturally adapted, mobile application for Black smokers by integrating information specifically relevant to Black persons with HIV/AIDS. (2) To conduct a randomized clinical trial for anxiety-sensitivity reduction and cigarette cessation among Black smokers with HIV.

Status (registry)
Completed
Study type
Interventional
Enrollment
76 (actual)
First submitted
23 Jan 2023
Start date
16 Oct 2023
Primary completion date
24 Jun 2025
Lead sponsor
University of Houston
Diseases
HIV
NCT number
NCT05709002

What you commit to

  • Study type: Interventional
  • Participants enrolled: 76
  • From 16 Oct 2023 to the primary completion date, 24 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Actively receiving (ongoing) pharmacotherapy or psychotherapy directly focused on the treatment of smoking cessation, and/or substance use, not provided by the study

Other illness

  • Cognitive impairment (assessed via the 6-item Cognitive Impairment Test)

Other

  • Non-fluent/limited English proficiency
  • Self-reported pregnancy or intentions to become pregnant in near future
  • Legal status that would interfere with participation
  • Being non-Black

Who the study is looking for

  • HIV-infection (via self-report and picture of medication, lab tests, or diagnosis)
  • 18+ years of age
  • Self-identify as Black / African American
  • Daily smoking (minimum of 10 cigarettes per day on average for at least 2 years)
  • Motivated to quit smoking (≥ 5 on a 10-point scale)
  • Willingness to discontinue cigarette use two weeks after baseline visit.
  • English literacy (score of 4 or greater on REALM-SF)
  • Moderate to high anxiety sensitivity (score of 5 or greater on SSASI)
  • Provide a current picture of their cigarette package to verify smoking status
  • Willing to complete all study surveys/assessments
  • Agree to use nicotine replacement medications (NRT; nicotine patch and lozenges)
  • Agree to attempt to quit smoking two weeks after completion of the baseline survey and receipt of study materials

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Thomas Street at Quentin Mease Health Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.